Literature DB >> 6870334

Plasma 17-hydroxyprogesterone concentrations in ill newborn infants.

J F Murphy, B G Joyce, J Dyas, I A Hughes.   

Abstract

Plasma 17-hydroxyprogesterone concentrations were determined in 47 preterm and term infants who were ill from a variety of causes. The results were compared with those in 53 healthy term infants. Mean plasma 17-hydroxyprogesterone values were appreciably higher in ill term and healthy preterm infants compared with healthy term infants, but the highest values were found in ill preterm infants. None of the infants had adrenal disease but some very ill infants had plasma 17-hydroxyprogesterone values approaching those seen in untreated infants with congenital adrenal hyperplasia. Interpretation of the results of plasma steroid measurements in newborn infants must take account of gestational age and the presence of stress related illness.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6870334      PMCID: PMC1628203          DOI: 10.1136/adc.58.7.532

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Serum androgen concentrations in neonates and young infants with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  S Pang; L S Levine; D M Chow; C Faiman; M I New
Journal:  Clin Endocrinol (Oxf)       Date:  1979-12       Impact factor: 3.478

2.  Early diagnosis of congenital adrenal hyperplasia by measurement of 17-hydroxyprogesterone.

Authors:  E Youssefnejadian; R David
Journal:  Clin Endocrinol (Oxf)       Date:  1975-07       Impact factor: 3.478

3.  Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia.

Authors:  S Pang; J Hotchkiss; A L Drash; L S Levine; M I New
Journal:  J Clin Endocrinol Metab       Date:  1977-11       Impact factor: 5.958

4.  Diagnosis of congenital adrenal hyperplasia by measurement of plasma 17-hydroxyprogesterone.

Authors:  N D Barnes; S M Atherden
Journal:  Arch Dis Child       Date:  1972-02       Impact factor: 3.791

5.  A pilot newborn screening for congenital adrenal hyperplasia in Alaska.

Authors:  S Pang; W Murphey; L S Levine; D A Spence; A Leon; S LaFranchi; A S Surve; M I New
Journal:  J Clin Endocrinol Metab       Date:  1982-09       Impact factor: 5.958

6.  Internal quality control of radioimmunoassays.

Authors:  K W Kemp; A B Nix; D W Wilson; K Griffiths
Journal:  J Endocrinol       Date:  1978-02       Impact factor: 4.286

7.  Ontogenic study of plasma 17alpha-hydroxyprogesterone in the human. I. Postnatal period: evidence for a transient ovarian activity in infancy.

Authors:  M G Forest; A M Cathiard
Journal:  Pediatr Res       Date:  1978-01       Impact factor: 3.756

8.  Plasma 17OH-progesterone concentrations in newborn infants.

Authors:  I A Hughes; D Riad-Fahmy; K Griffiths
Journal:  Arch Dis Child       Date:  1979-05       Impact factor: 3.791

9.  A method for identification and follow-up of patients with a steroid-21-hydroxylase deficiency.

Authors:  J Sólyom; G L Hammond; R Vihko
Journal:  Clin Chim Acta       Date:  1979-03-01       Impact factor: 3.786

10.  Plasma levels of aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, cortisol, and cortisone during infancy and childhood.

Authors:  W G Sippell; H G Dörr; F Bidlingmaier; D Knorr
Journal:  Pediatr Res       Date:  1980-01       Impact factor: 3.756

View more
  16 in total

1.  Biochemical aspects of congenital adrenal hyperplasia.

Authors:  J Honour
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Review of CAH screening programmes and the Scottish experience.

Authors:  A M Wallace
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

3.  Clinical aspects of congenital adrenal hyperplasia: early diagnosis and prognosis.

Authors:  I A Hughes
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

4.  Neonatal screening for congenital adrenal hyperplasia: a pilot study in France.

Authors:  J L Dhondt; C Dorche; J P Farriaux; C Courte
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

Review 5.  Management of congenital adrenal hyperplasia.

Authors:  I A Hughes
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

6.  The influence of seasonality and manufacturer kit lot changes on 17α-hydroxyprogesterone measurements and referral rates of congenital adrenal hyperplasia in newborns.

Authors:  Melissa Pearce; Erin Dauerer; A Gregory DiRienzo; Michele Caggana; Norma P Tavakoli
Journal:  Eur J Pediatr       Date:  2016-11-29       Impact factor: 3.183

7.  Response to ACTH in the newborn.

Authors:  S Thomas; J F Murphy; J Dyas; M Ryalls; I A Hughes
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

8.  Value of selective screening for congenital adrenal hyperplasia in Hungary.

Authors:  J Sólyom; I A Hughes
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

9.  Blood spot glucocorticoid concentrations in ill preterm infants.

Authors:  D Hughes; J F Murphy; J Dyas; J A Robinson; D Riad-Fahmy; I A Hughes
Journal:  Arch Dis Child       Date:  1987-10       Impact factor: 3.791

10.  Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.

Authors:  J Sólyom
Journal:  Arch Dis Child       Date:  1984-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.